Analyst Comment

Embla Medical – Recording of Q3 2024 result presentation

Today, Embla Medical's CEO Sveinn Solvason presented and answered questions about the Q3 2024 results, the expectations for the rest of the year, and details about the increased reimbursement on the US market. Changes that creates a large market potential trough access to more advanced solutions for patients.

https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q3-2024

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 15:38, 23 October 2024.

Login required

This content is only available for logged in users

Create account

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.